Literature DB >> 9733871

Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

J L Riley1, B L Levine, N Craighead, T Francomano, D Kim, R G Carroll, C H June.   

Abstract

In vitro evidence suggests that memory CD4(+) cells are preferentially infected by human immunodeficiency virus type 1 (HIV-1), yet studies of HIV-1-infected individuals have failed to detect preferential memory cell depletion. To explore this paradox, we stimulated CD45RA+ CD4(+) (naïve) and CD45RO+ CD4(+) (memory) cells with antibodies to CD3 and CD28 and infected them with either CCR5-dependent (R5) or CXCR4-dependent (X4) HIV-1 isolates. Naïve CD4(+) cells supported less X4 HIV replication than their memory counterparts. However, naïve cells were susceptible to R5 viral infection, while memory cells remained resistant to infection and viral replication. As with the unseparated cells, mixing the naïve and memory cells prior to infection resulted in cells resistant to R5 infection and highly susceptible to X4 infection. While both naïve and memory CD4(+) subsets downregulated CCR5 expression in response to CD28 costimulation, only the memory cells produced high levels of the beta-chemokines RANTES, MIP-1alpha, and MIP-1beta upon stimulation. Neutralization of these beta-chemokines rendered memory CD4(+) cells highly sensitive to infection with R5 HIV-1 isolates, indicating that downregulation of CCR5 is not sufficient to mediate complete protection from CCR5 strains of HIV-1. These results indicate that susceptibility to R5 HIV-1 isolates is determined not only by the level of CCR5 expression but also by the balance of CCR5 expression and beta-chemokine production. Furthermore, our results suggest a model of HIV-1 transmission and pathogenesis in which naïve rather than memory CD4(+) T cells serve as the targets for early rounds of HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733871      PMCID: PMC110187     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing.

Authors:  D Unutmaz; D R Littman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

5.  The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation.

Authors:  L T Clement; N Yamashita; A M Martin
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

6.  T-cell dynamics of immunodeficiency.

Authors:  M Roederer
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

7.  Human naive and memory T lymphocytes differ in telomeric length and replicative potential.

Authors:  N P Weng; B L Levine; C H June; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

9.  T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study.

Authors:  J V Giorgi; R Detels
Journal:  Clin Immunol Immunopathol       Date:  1989-07

10.  Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Authors:  R I Connor; K E Sheridan; D Ceradini; S Choe; N R Landau
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  23 in total

1.  Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue.

Authors:  J C Grivel; M L Penn; D A Eckstein; B Schramm; R F Speck; N W Abbey; B Herndier; L Margolis; M A Goldsmith
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  A dichotomy in cortical actin and chemotactic actin activity between human memory and naive T cells contributes to their differential susceptibility to HIV-1 infection.

Authors:  Weifeng Wang; Jia Guo; Dongyang Yu; Paul J Vorster; WanJun Chen; Yuntao Wu
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

4.  Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.

Authors:  J T Qiu; B Liu; C Tian; G N Pavlakis; X F Yu
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

Authors:  Marloes A Naarding; Irene S Ludwig; Fedde Groot; Ben Berkhout; Teunis B H Geijtenbeek; Georgios Pollakis; William A Paxton
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

6.  Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells.

Authors:  Jihong Dai; Luis M Agosto; Clifford Baytop; Jianqing J Yu; Matthew J Pace; Megan K Liszewski; Una O'Doherty
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Authors:  Max W Richardson; Julie Jadlowsky; Chuka A Didigu; Robert W Doms; James L Riley
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

9.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

10.  HIV-1 Nef and T-cell activation: a history of contradictions.

Authors:  Tristan J Markle; Mwimanzi Philip; Mark A Brockman
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.